Protocol Ledger

Academic / Institutional Sponsor · Consolidated Sponsor Hub

Oregon Health and Science University: Clinical Trials & FDA Approval Profile

Oregon Health and Science University (Global / Institutional) sponsors 29 reconciled interventional Phase II and Phase III ClinicalTrials.gov studies (2018 to 2026), including 11 active protocols (6 recruiting now), 9 completed protocols, and 0 all-time original FDA Drugs@FDA NDA and BLA approvals.

Track in Studio / Generate Client Brief ->
Early-Stop Rate vs National (13.8%)10.3%
Median Closed Enrollment vs National (145 pts)21 participants

Verified Sponsor Execution & Regulatory Ledger

Reconciled ClinicalTrials.gov v2 & Drugs@FDA Metrics for Oregon Health and Science University
Sponsor MetricVerified Count / Rate
Phase II & III Protocols (2018 to 2026)29
Active Pipeline (Recruiting Now)11 (6)
Completed vs Stopped Early9 / 3 (10.3%)
Median Closed Actual Enrollment21 participants
Physical Hospital Site Disclosure100.0% named hospitals
FDA Drugs@FDA Original NDA/BLA Approvals0 (0 since 2018)

Top Partner U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Partnered With Oregon Health and Science University
Hospital Research SiteLocationShared Protocols
Oregon Health and Science University Knight Cancer InstitutePortland, OR22

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for Oregon Health & Science University (OHSU) across sibling Meru public-data platforms.

Explore interactive annual charts and M&A subsidiary rollups in the Oregon Health and Science University Interactive Dossier, benchmark peers in Rare Genetic, Women's Health, and Other, or review the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI